{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:57:18Z","timestamp":1784699838113,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10050-7","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:40:29Z","timestamp":1730104829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical epidemiology and impact of Haemophilus influenzae airway infections in adults with cystic fibrosis"],"prefix":"10.1186","volume":"24","author":[{"given":"R. Benson","family":"Weyant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Izydorczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Conly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre L.","family":"Church","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Surette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"key":"10050_CR1","doi-asserted-by":"publisher","first-page":"10241","DOI":"10.1038\/srep10241","volume":"5","author":"B Coburn","year":"2015","unstructured":"Coburn B, Wang PW, Diaz Caballero J, Clark ST, Brahma V, Donaldson S, et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015;5:10241.","journal-title":"Sci Rep"},{"key":"10050_CR2","doi-asserted-by":"crossref","unstructured":"Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP et al. Airway Microbiota across age and disease spectrum in cystic fibrosis. European Respiratory Journal. 2017 Nov 1; 50(5).","DOI":"10.1183\/13993003.00832-2017"},{"issue":"15","key":"10050_CR3","doi-asserted-by":"publisher","first-page":"5809","DOI":"10.1073\/pnas.1120577109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2012;109(15):5809\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10050_CR4","unstructured":"Cystic Fibrosis Foundation Patient Registry. 2019 Annual Data Report [Internet]. 2019 [cited 2024 Feb 8]. https:\/\/www.cff.org\/sites\/default\/files\/2021-10\/2019-Patient-Registry-Annual-Data-Report.pdf"},{"issue":"2","key":"10050_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1128\/CMR.00068-09","volume":"23","author":"JJ LiPuma","year":"2010","unstructured":"LiPuma JJ. The changing Microbial Epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23(2):299\u2013323.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10050_CR6","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1128\/JCM.42.4.1450-1459.2004","volume":"42","author":"F Rom\u00e1n","year":"2004","unstructured":"Rom\u00e1n F, Cant\u00f3n R, P\u00e9rez-V\u00e1zquez M, Baquero F, Campos J. Dynamics of Long-Term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in Hypermutable Strains. J Clin Microbiol. 2004;42(4):1450\u20139.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10050_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/adc.65.3.255","volume":"65","author":"RJ Rayner","year":"1990","unstructured":"Rayner RJ, Hiller EJ, Ispahani P, Baker M. Haemophilus infection in cystic fibrosis. Arch Dis Child. 1990;65(3):255\u20138.","journal-title":"Arch Dis Child"},{"key":"10050_CR8","unstructured":"UK Cystic Fibrosis Trust Antibiotic Working Group. Antibiotic treatment for cystic fibrosis \u2013 3rd edition [Internet]. 2009. https:\/\/www.cysticfibrosis.org.uk\/sites\/default\/files\/2020-11\/Anitbiotic%20Treatment.pdf"},{"issue":"9","key":"10050_CR9","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1128\/JCM.00814-12","volume":"50","author":"T Spilker","year":"2012","unstructured":"Spilker T, Vandamme P, LiPuma JJ. A multilocus sequence typing scheme implies population structure and reveals several putative novel achromobacter species. J Clin Microbiol. 2012;50(9):3010\u20135.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10050_CR10","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/JCM.03218-13","volume":"52","author":"MD Parkins","year":"2014","unstructured":"Parkins MD, Glezerson BA, Sibley CD, Sibley KA, Duong J, Purighalla S, et al. Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain. J Clin Microbiol. 2014;52(4):1127\u201335.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10050_CR11","doi-asserted-by":"publisher","first-page":"15765","DOI":"10.1038\/s41598-022-19240-2","volume":"12","author":"C Izydorczyk","year":"2022","unstructured":"Izydorczyk C, Waddell BJ, Weyant RB, Surette MG, Somayaji R, Rabin HR, et al. The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis. Sci Rep. 2022;12(1):15765.","journal-title":"Sci Rep"},{"issue":"10","key":"10050_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1056\/NEJM199409083311003","volume":"331","author":"HJ Fuchs","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994;331(10):637\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"10050_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12879-015-0856-5","volume":"15","author":"JC Lam","year":"2015","unstructured":"Lam JC, Somayaji R, Surette MG, Rabin HR, Parkins MD. Reduction in Pseudomonas aeruginosa Sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. BMC Infect Dis. 2015;15(1):145.","journal-title":"BMC Infect Dis"},{"key":"10050_CR14","volume-title":"CLSI","author":"Performance Standards for Antimicrobial Susceptibility Testing. In","year":"2017","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing. In. CLSI. 27th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017. CLSI Supplement M100.","edition":"27"},{"issue":"9","key":"10050_CR15","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","volume":"33","author":"FC Tenover","year":"1995","unstructured":"Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33(9):2233\u20139.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10050_CR16","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1128\/JCM.02509-10","volume":"49","author":"GS Davis","year":"2011","unstructured":"Davis GS, Sandstedt SA, Patel M, Marrs CF, Gilsdorf JR. Use of bexB to detect the Capsule Locus in Haemophilus influenzae. J Clin Microbiol. 2011;49(7):2594\u2013601.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10050_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/s12864-019-6145-8","volume":"20","author":"CC Potts","year":"2019","unstructured":"Potts CC, Topaz N, Rodriguez-Rivera LD, Hu F, Chang HY, Whaley MJ, et al. Genomic characterization of Haemophilus influenzae: a focus on the capsule locus. BMC Genomics. 2019;20(1):733.","journal-title":"BMC Genomics"},{"key":"10050_CR18","doi-asserted-by":"crossref","unstructured":"Watts SC, Judd LM, Carzino R, Ranganathan S, Holt KE. Genomic diversity and Antimicrobial Resistance of Haemophilus colonizing the airways of Young children with cystic fibrosis. mSystems. 2021;6(4):e00178-21.","DOI":"10.1128\/msystems.00178-21"},{"issue":"1","key":"10050_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijmm.2011.08.003","volume":"302","author":"R Cardines","year":"2012","unstructured":"Cardines R, Giufr\u00e8 M, Pompilio A, Fiscarelli E, Ricciotti G, Bonaventura GD, et al. Haemophilus influenzae in children with cystic fibrosis: Antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation. Int J Med Microbiol. 2012;302(1):45\u201352.","journal-title":"Int J Med Microbiol"},{"issue":"5","key":"10050_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/infdis\/172.5.1388","volume":"172","author":"LVM M\u00f6ller","year":"1995","unstructured":"M\u00f6ller LVM, Regelink AG, Grasselier H, Dankert-Roelse JE, Dankert J, van Alphen L. Multiple Haemophilus influenzae strains and strain variants coexist in the respiratory tract of patients with cystic fibrosis. J Infect Dis. 1995;172(5):1388\u201392.","journal-title":"J Infect Dis"},{"issue":"24","key":"10050_CR21","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1016\/j.vaccine.2010.03.075","volume":"28","author":"HJ Adam","year":"2010","unstructured":"Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine. 2010;28(24):4073\u20138.","journal-title":"Vaccine"},{"issue":"2","key":"10050_CR22","doi-asserted-by":"publisher","first-page":"e00803","DOI":"10.1128\/Spectrum.00803-21","volume":"9","author":"LR McTaggart","year":"2021","unstructured":"McTaggart LR, Cronin K, Seo CY, Wilson S, Patel SN, Kus JV. Increased incidence of Invasive Haemophilus influenzae Disease Driven by Non-type B isolates in Ontario, Canada, 2014 to 2018. Microbiol Spectr. 2021;9(2):e00803\u201321.","journal-title":"Microbiol Spectr"},{"issue":"7","key":"10050_CR23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ijporl.2012.02.043","volume":"76","author":"GP Digoy","year":"2012","unstructured":"Digoy GP, Dunn JD, Stoner JA, Christie A, Jones DT. Bacteriology of the paranasal sinuses in pediatric cystic fibrosis patients. Int J Pediatr Otorhinolaryngol. 2012;76(7):934\u20138.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"5","key":"10050_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ppul.20396","volume":"41","author":"MS Muhlebach","year":"2006","unstructured":"Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol. 2006;41(5):445\u201351.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10050_CR25","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41598-019-42862-y","volume":"9","author":"TE Woo","year":"2019","unstructured":"Woo TE, Lim R, Heirali AA, Acosta N, Rabin HR, Mody CH, et al. A longitudinal characterization of the Non-cystic Fibrosis Bronchiectasis airway microbiome. Sci Rep. 2019;9(1):6871.","journal-title":"Sci Rep"},{"issue":"1","key":"10050_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ismej.2014.124","volume":"9","author":"GB Rogers","year":"2015","unstructured":"Rogers GB, van der Gast CJ, Serisier DJ. Predominant pathogen competition and core microbiota divergence in chronic airway infection. ISME J. 2015;9(1):217\u201325.","journal-title":"ISME J"},{"issue":"7","key":"10050_CR27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/cid\/ciy215","volume":"67","author":"MR Crull","year":"2018","unstructured":"Crull MR, Somayaji R, Ramos KJ, Caldwell E, Mayer-Hamblett N, Aitken ML, et al. Changing Rates of Chronic Pseudomonas aeruginosa infections in cystic fibrosis: a Population-based Cohort Study. Clin Infect Dis. 2018;67(7):1089\u201395.","journal-title":"Clin Infect Dis"},{"key":"10050_CR28","unstructured":"Hewer SCL, Smyth AR. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database of Systematic Reviews. 2017;(4)."},{"issue":"6","key":"10050_CR29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jcf.2021.11.003","volume":"21","author":"LM Sosinski","year":"2022","unstructured":"Sosinski LM, Neugebauer HCM, Ghuneim KA, Guzior LAJ, Castillo-Bahena DV. A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung. J Cyst Fibros off J Eur Cyst Fibros Soc. 2022;21(6):996\u20131005.","journal-title":"J Cyst Fibros off J Eur Cyst Fibros Soc"},{"key":"10050_CR30","unstructured":"Gessner B, Njanpop-Lafourcade BM, Herbert M. Haemophilus influenzae- Infectious Disease and Antimicrobial Agents [Internet]. [cited 2024 Feb 8]. http:\/\/antimicrobe.org\/b67.asp"},{"issue":"2","key":"10050_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/AAC.9.2.274","volume":"9","author":"M Finland","year":"1976","unstructured":"Finland M, Garner C, Wilcox C, Sabath LD. Susceptibility of Pneumococci and Haemophilus influenzae to Antibacterial agents. Antimicrob Agents Chemother. 1976;9(2):274\u201387.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10050-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10050-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:40:40Z","timestamp":1730104840000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10050-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10050"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10050-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the University of Calgary Conjoint Regional Health Ethics Board with the following reference numbers: REB15\u20130854 and REB15\u20132744. Patients were recruited from the Calgary Adult CF Clinic and all patients provide written informed consent for the collection and storage of specimens and subsequent analysis. All samples were de-identified. Patients have contributed samples to this regional ethics board (REB) collection from 1998-present (REB15\u20130854) and provide consent for ongoing research purposes (REB15\u20132744).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1209"}}